Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3

Harsh Patolia1, Muhammad Shahzeb Khan2, Gregg C Fonarow3

  • 1Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Insights

Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) is underutilized, despite its proven benefits. This review explores implementation strategies to improve GDMT delivery and patient outcomes.

Area of Science:

  • Cardiology
  • Implementation Science

Background:

  • Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of mortality and hospitalization.
  • Significant gaps exist in the utilization of guideline-directed medical therapy (GDMT) for eligible HFrEF patients.
  • Despite available therapies, suboptimal care delivery persists, highlighting an urgent need for improved treatment strategies.

Purpose of the Study:

  • To review and contextualize evidence for various implementation strategies aimed at improving GDMT utilization in HFrEF.
  • To identify effective methods for bridging the gap between guideline recommendations and clinical practice for HFrEF management.

Main Methods:

  • Comprehensive review of existing literature on implementation strategies for HFrEF GDMT.
  • Analysis of evidence supporting various approaches, including in-hospital initiation, multidisciplinary clinics, and digital health interventions.

Main Results:

  • Multiple evidence-based strategies can enhance GDMT delivery for HFrEF.
  • Successful implementation requires tailored approaches, addressing barriers like cost, patient education, and system integration.
  • Initiatives range from direct patient engagement to leveraging electronic health records and quality improvement programs.

Conclusions:

  • Improving GDMT uptake in HFrEF is feasible through diverse implementation strategies.
  • A multi-faceted approach combining clinical interventions, system-level changes, and patient-centered education is crucial.
  • Optimizing GDMT delivery can significantly reduce HFrEF-related morbidity and mortality.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
96
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463